Bayesian Adaptive Design for Immunotherapy and Targeted Therapy

Haitao Pan () and Ying Yuan ()
Additional contact information
Haitao Pan: St. Jude Children's Research Hospital, Department of Biostatistics
Ying Yuan: The University of Texas, Department of Biostatistics, MD Anderson Cancer Center

in Springer Books from Springer

Date: 2023
ISBN: 978-981-19-8176-0
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Chapters in this book:

Ch Chapter 1 Introduction to Phase I Dose-Finding Clinical Trials

Haitao Pan and Ying Yuan

Ch Chapter 2 Phase I Designs for Late-Onset Toxicity

Haitao Pan and Ying Yuan

Ch Chapter 3 Optimal Biological Dose and Phase I/II Trials

Haitao Pan and Ying Yuan

Ch Chapter 4 Model-Based Designs for Identification of Optimal Biological Dose

Haitao Pan and Ying Yuan

Ch Chapter 5 Model-Assisted Designs for Identifying the Optimal Biological Dose

Haitao Pan and Ying Yuan

Ch Chapter 6 Single Arm Phase II Clinical Trial

Haitao Pan and Ying Yuan

Ch Chapter 7 Randomized Phase II Designs

Haitao Pan and Ying Yuan

Ch Chapter 8 Introduction to Basket Trials

Haitao Pan and Ying Yuan

Ch Chapter 9 Platform Trials

Haitao Pan and Ying Yuan

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprbok:978-981-19-8176-0

Ordering information: This item can be ordered from
http://www.springer.com/9789811981760

DOI: 10.1007/978-981-19-8176-0

Access Statistics for this book

More books in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().